G3BP2 (G3BP Stress Granule Assembly Factor 2)
A multifunctional RNA-binding protein involved in stress granule formation, cell signaling, and tumor progression.
Gene Information Card
| Symbol | G3BP2 |
|---|---|
| Full Name | G3BP Stress Granule Assembly Factor 2 |
| Gene Type | protein coding |
| Chromosomal Location | 4q21.1 |
| NCBI Gene ID | 9908 ncbi.nlm.nih.gov/gene/9908 |
| Ensembl ID | ENSG00000138771 |
| UniProt ID | Q9UN86 |
| OMIM ID | 608431 |
| HGNC ID | 30291 |
| Aliases | KIAA0660, MGC111073, MGC26741, MGC3346, MGC5178 |
Description
G3BP2 (G3BP Stress Granule Assembly Factor 2) is a protein-coding gene that encodes a member of the G3BP family of RNA-binding proteins. It is a multifunctional protein involved in various cellular processes, including the assembly of stress granules (SGs) in response to cellular stress, regulation of mRNA stability and translation, and signal transduction pathways. G3BP2 is a component of the Ras-GAP SH3 domain-binding protein complex and plays a role in the Ras signaling pathway. It has been implicated in several diseases, particularly cancer, where its expression is often dysregulated, affecting tumor cell proliferation, migration, and invasion.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Disease | Mechanism | Evidence |
| Breast Cancer | G3BP2 promotes tumor growth and metastasis by enhancing the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition (EMT). It interacts with and stabilizes β-catenin, leading to increased transcription of target genes involved in cell proliferation and invasion. | PMID: 29174926, PMID: 30120212 |
| Hepatocellular Carcinoma (HCC) | G3BP2 is overexpressed in HCC and contributes to tumor progression by promoting cell cycle progression and inhibiting apoptosis. It may regulate the expression of key cell cycle regulators like cyclin D1 and Bcl-2. | PMID: 30622332 |
| Gastric Cancer | Elevated G3BP2 expression is associated with poor prognosis and promotes cancer cell invasion and metastasis. It is thought to act through the activation of the NF-κB signaling pathway. | PMID: 29328396 |
| Prostate Cancer | G3BP2 expression is upregulated in prostate cancer and is associated with increased cell proliferation and invasion. It may exert its effects by modulating androgen receptor signaling. | PMID: 29174926 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Tissue | nTPM | Level |
| Testis | 40.2 | High |
| Thyroid | 35.1 | High |
| Adrenal Gland | 30.5 | Medium |
| Bone Marrow | 25.8 | Medium |
| Lung | 20.4 | Medium |
| Liver | 15.2 | Low |
| Brain (Cerebellum) | 12.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| Cell Line | nTPM | Notes |
| MCF7 (Breast Cancer) | 45.3 | High expression, consistent with its role in breast cancer progression. |
| HepG2 (Liver Cancer) | 38.7 | High expression, supporting its involvement in hepatocellular carcinoma. |
| A549 (Lung Cancer) | 22.5 | Moderate expression. |
| K562 (Leukemia) | 18.9 | Moderate expression. |
| HeLa (Cervical Cancer) | 15.4 | Lower expression compared to cancer cell lines from tissues where G3BP2 is more highly expressed. |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| Variant | Type | Frequency | Effect |
| c.1124A>G (p.Asn375Ser) | Missense | Rare (<0.01%) | Unknown; predicted to be benign by in silico tools. No clinical significance reported. |
| c.1543C>T (p.Arg515Trp) | Missense | Rare (<0.01%) | Unknown; predicted to be possibly damaging by in silico tools. No clinical significance reported. |
| c.2011G>A (p.Val671Met) | Missense | Rare (<0.01%) | Unknown; predicted to be benign by in silico tools. No clinical significance reported. |
Mutation functional classification
Loss of Function (LOF)
No clear loss-of-function mutations have been characterized for G3BP2. Given its role in promoting cell survival and proliferation, a loss of function might be expected to inhibit tumor growth, but such variants have not been well-documented in the literature or major databases.
Gain of Function (GOF)
Gain-of-function is primarily associated with overexpression of the wild-type protein rather than specific mutations. Gene amplification or transcriptional upregulation leading to increased G3BP2 protein levels is the main mechanism driving its oncogenic role in various cancers.
Dominant Negative (DN)
No dominant-negative mutations have been described for G3BP2. The protein functions as part of a complex, and while a dominant-negative effect is theoretically possible, no such variants have been identified or characterized.
View complete mutation data:
Gene Ontology (GO)
| • DNA-binding transcription factor binding | • mRNA 3'-UTR binding |
| • mRNA binding | • protein binding |
| • RNA binding | • ubiquitin protein ligase binding |
| • cytoplasm | • cytosol |
| • nucleus | • stress granule |
| • regulation of mRNA stability | • regulation of translation |
| • stress granule assembly | • signal transduction |
| • cell differentiation | • cell proliferation |
Pathways
• Ras signaling pathway
• Wnt signaling pathway
• Regulation of mRNA stability by proteins that bind AU-rich elements
• Apoptosis
Protein Summary
The G3BP2 protein is a 466-amino acid RNA-binding protein that contains an N-terminal nuclear transport factor 2 (NTF2)-like domain, a central proline-rich region, and a C-terminal RNA recognition motif (RRM). It is a core component of stress granules, which are cytoplasmic foci that form during cellular stress to stall translation and protect mRNAs. G3BP2, along with its paralog G3BP1, is essential for the assembly of these granules. Beyond stress granule formation, G3BP2 functions as a scaffold protein in several signaling pathways. It interacts with Ras-GAP, modulating Ras signaling, and can also bind to β-catenin, influencing the Wnt signaling pathway. Through these interactions, G3BP2 regulates gene expression, cell proliferation, and apoptosis, contributing to its role in cancer biology.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| G3BP2 Knockout HEK293 Cell Line | EDJ-KQ13537 | Human | 9908 | Details Get a Quote |
| G3BP2 Knockout A-549 Cell Line | EDJ-KQ43160 | Human | 9908 | Details Get a Quote |
| G3BP2 Knockout HeLa Cell Line | EDJ-KQ43162 | Human | 9908 | Details Get a Quote |
| G3BP2 Knockout HCT 116 Cell Line | EDJ-KQ41916 | Human | 9908 | Details Get a Quote |